Neurochemokines: A menage a trois providing new insights on the functions of chemokines in the central nervous system

Journal of Neurochemistry

Volumn 118, Issue 5, 2011, Pages 680-694

  Rostène, William ^a   Dansereau, Marc André ^b   Godefroy, David ^a   Van Steenwinckel, Juliette ^c   Goazigo, Annabelle Reaux Le ^c   Mélik Parsadaniantz, Stéphane ^c   Apartis, Emmanuelle ^d   Hunot, Stéphane ^c   Beaudet, Nicolas ^b   Sarret, Philippe ^b  

^a INSTITUT DE LA VISION   (France)

^b UNIVERSITY OF SHERBROOKE   (Canada)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

inflammation; microglia; neurodegenerative diseases; neuron; pain; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIINFLAMMATORY AGENT; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL N TYPE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CXCL1 CHEMOKINE; DEXAMETHASONE; DOPAMINE; FRACTALKINE; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 8; MACROPHAGE DERIVED CHEMOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MORPHINE SULFATE; N [2 [[1 [4 (1,3 BENZODIOXOL 5 YL) 4 HYDROXYCYCLOHEXYL] 4 ETHOXY 3 PYRROLIDINYL]AMINO] 2 OXOETHYL] 3 (TRIFLUOROMETHYL)BENZAMIDE; OXIDOPAMINE; PLERIXAFOR; RANTES; SODIUM CHANNEL NAV1.8; STROMAL CELL DERIVED FACTOR 1; SUBSTANCE P; VOLTAGE GATED CALCIUM CHANNEL;

ALZHEIMER DISEASE; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ASTROCYTOSIS; AUTOCRINE EFFECT; AUTORADIOGRAPHY; BINDING SITE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN REGION; CELL ACTIVATION; CELL ACTIVITY; CELL COMMUNICATION; CELL INFILTRATION; CELL MEMBRANE DEPOLARIZATION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM FUNCTION; CHRONIC PAIN; DISEASE COURSE; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ELECTROENCEPHALOGRAM; ENCEPHALITIS; ENZYME ACTIVATION; ENZYME INHIBITION; GLIA CELL; HUMAN; HYPERALGESIA; IMMUNE RESPONSE; INTRACELLULAR SIGNALING; LOCOMOTION; MEMBRANE CONDUCTANCE; MICROGLIA; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NERVE CELL NETWORK; NERVE COMPRESSION; NERVE CONDUCTION; NERVE ENDING; NERVE POTENTIAL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMODULATION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PARKINSON DISEASE; POTASSIUM CONDUCTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TARGETING; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL PROCESSING; STIMULUS RESPONSE; STROKE;

EID: 80051789712     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07371.x     Document Type: Review

References (130)

1. Abbadie C., Lindia J. A., Cumiskey A. M., Peterson L. B., Mudgett J. S., Bayne E. K., DeMartino J. A., MacIntyre D. E., and, Forrest M. J., (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl Acad. Sci. USA 100, 7947-7952. (Pubitemid 36760075)
2. Bajetto A., Bonavia R., Barbero S., Piccioli P., Costa A., Florio T., and, Schettini G., (1999) Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73, 2348-2357.
3. Ban E., Haour F., and, Lenstra R., (1992) Brain interleukin 1 gene expression induced by peripheral lipopolysaccharide administration. Cytokine 4, 48-54.
4. Ban E., Marquette C., Sarrieau A., Fitzpatrick F., Fillion G., Milon G., Rostene W., and, Haour F., (1993) Regulation of interleukin-1 receptor expression in mouse brain and pituitary by lipopolysaccharide and glucocorticoids. Neuroendocrinology 58, 581-587. (Pubitemid 23343942)
5. Banisadr G., Dicou E., Berbar T., Rostene W., Lombet A., and, Haour F., (2000) Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells. J. Neuroimmunol. 110, 151-160.
6. Banisadr G., Fontanges P., Haour F., Kitabgi P., Rostene W., and, Melik Parsadaniantz S., (2002) Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur. J. Neurosci. 16, 1661-1671. (Pubitemid 35370698)
7. Banisadr G., Skrzydelski D., Kitabgi P., Rostene W., and, Parsadaniantz S. M., (2003) Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18, 1593-1606. (Pubitemid 37215112)
8. Banisadr G., Gosselin R. D., Mechighel P., Kitabgi P., Rostene W., and, Parsadaniantz S. M., (2005a) Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J. Comp. Neurol. 489, 275-292. (Pubitemid 41026230)
9. Banisadr G., Gosselin R. D., Mechighel P., Rostene W., Kitabgi P., and, Melik Parsadaniantz S., (2005b) Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J. Comp. Neurol. 492, 178-192. (Pubitemid 41443720)
10. Belmadani A., Tran P. B., Ren D., Assimacopoulos S., Grove E. A., and, Miller R. J., (2005) The chemokine stromal cell-derived factor-1 regulates the migration of sensory neuron progenitors. J. Neurosci. 25, 3995-4003. (Pubitemid 40563374)
11. Belmadani A., Tran P. B., Ren D., and, Miller R. J., (2006) Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26, 3182-3191.
12. Bezzi P., Domercq M., Brambilla L., et al. (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat. Neurosci. 4, 702-710. (Pubitemid 32595408)
13. Bhangoo S., Ren D., Miller R. J., et al. (2007) Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol. Pain. 3, 38-58.
14. Bhangoo S. K., Ripsch M. S., Buchanan D. J., Miller R. J., and, White F. A., (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol. Pain. 5, 48-66.
15. Bhattacharyya B. J., Banisadr G., Jung H., Ren D., Cronshaw D. G., Zou Y., and, Miller R. J., (2008) The chemokine stromal cell-derived factor-1 regulates GABAergic inputs to neural progenitors in the postnatal dentate gyrus. J. Neurosci. 28, 6720-6730.
16. Biber K., Sauter A., Brouwer N., Copray S. C., and, Boddeke H. W., (2001) Ischemia-induced neuronal expression of the microglia attracting chemokine secondary lymphoid-tissue chemokine (SLC). Glia 34, 121-133. (Pubitemid 32480591)
17. Biber K., Neumann H., Inoue K., and, Boddeke H. W., (2007) Neuronal 'On' and 'Off' signals control microglia. Trends Neurosci. 30, 596-602. (Pubitemid 350051426)
18. Blalock J. E., (1989) A molecular basis for bidirectional communication between the immune and neuroendocrine systems. Physiol. Rev. 69, 1-32. (Pubitemid 19040135)
19. Bleul C. C., Farzan M., Choe H., Parolin C., Clark-Lewis I., Sodroski J., and, Springer T. A., (1996) The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-833. (Pubitemid 26299570)
20. Breder C. D., Dinarello C. A., and, Saper C. B., (1988) Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 240, 321-324.
21. Brochard V., Combadiere B., Prigent A., et al. (2009) Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119, 182-192.
22. Callewaere C., Banisadr G., Desarmenien M. G., Mechighel P., Kitabgi P., Rostene W. H., and, Melik Parsadaniantz S., (2006) The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc. Natl Acad. Sci. USA 103, 8221-8226. (Pubitemid 43801079)
23. Cardona A. E., Li M., Liu L., Savarin C., and, Ransohoff R. M., (2008) Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J. Leukoc. Biol. 84, 587-594.
24. Cocchi F., DeVico A. L., Garzino-Demo A., Arya S. K., Gallo R. C., and, Lusso P., (1995) Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270, 1811-1815.
25. Conductier G., Blondeau N., Guyon A., Nahon J. L., and, Rovere C., (2010) The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases. J. Neuroimmunol. 224, 93-100.
26. Constantin G., (2008) Chemokine signaling and integrin activation in lymphocyte migration into the inflamed brain. J. Neuroimmunol. 198, 20-26.
27. Coughlan C. M., McManus C. M., Sharron M., et al. (2000) Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97, 591-600. (Pubitemid 30320765)
28. Czlonkowska A., and, Kurkowska-Jastrzebska I., (2010) Inflammation and gliosis in neurological diseases-clinical implications. J. Neuroimmunol. 231, 78-85.
29. Dana C., Vial M., Leonard K., Beauregard A., Kitabgi P., Vincent J. P., Rostene W., and, Beaudet A., (1989) Electron microscopic localization of neurotensin binding sites in the midbrain tegmentum of the rat. I. Ventral tegmental area and the interfascicular nucleus. J. Neurosci. 9, 2247-2257. (Pubitemid 19193558)
30. Dansereau M. A., Gosselin R. D., Pohl M., et al. (2008) Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats. J. Neurochem. 106, 757-769.
31. Escartin C., and, Bonvento G., (2008) Targeted activation of astrocytes: a potential neuroprotective strategy. Mol. Neurobiol. 38, 231-241.
32. Felszeghy K., Banisadr G., Rostene W., Nyakas C., and, Haour F., (2004) Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats. Neuroimmunomodulation 11, 404-413. (Pubitemid 39370447)
33. Feng Y., Broder C. C., Kennedy P. E., and, Berger E. A., (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877. (Pubitemid 26154590)
34. Gao Y. J., Zhang L., Samad O. A., Suter M. R., Yasuhiko K., Xu Z. Z., Park J. Y., Lind A. L., Ma Q., and, Ji R. R., (2009) JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J. Neurosci. 29, 4096-4108.
35. Giovannelli A., Limatola C., Ragozzino D., Mileo A. M., Ruggieri A., Ciotti M. T., Mercanti D., Santoni A., and, Eusebi F., (1998) CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J. Neuroimmunol. 92, 122-132. (Pubitemid 29015997)
36. Gosselin R. D., Varela C., Banisadr G., Mechighel P., Rostene W., Kitabgi P., and, Melik-Parsadaniantz S., (2005) Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J. Neurochem. 95, 1023-1034. (Pubitemid 41713487)
37. Guyon A., and, Nahon J. L., (2007) Multiple actions of the chemokine stromal cell-derived factor-1alpha on neuronal activity. J. Mol. Endocrinol. 38, 365-376. (Pubitemid 46723252)
38. Guyon A., Skrzydelsi D., Rovere C., Rostene W., Parsadaniantz S. M., and, Nahon J. L., (2006) Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J. Neurochem. 96, 1540-1550. (Pubitemid 43351614)
39. Guyon A., Skrzydelski D., De Giry I., et al. (2009) Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience 162, 1072-1080.
40. de Haas A. H., van Weering H. R., de Jong E. K., Boddeke H. W., and, Biber K. P., (2007) Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol. Neurobiol. 36, 137-151. (Pubitemid 351360343)
41. Harrison J. K., and, Lukacs N. W., (2007) The Chemokine Receptors. Humana Press, Totawa, New Jersey.
42. Huber J. D., Campos C. R., Mark K. S., and, Davis T. P., (2006) Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain. Am. J. Physiol. Heart Circ. Physiol. 290, H732-H740.
43. de Jong E. K., Dijkstra I. M., Hensens M., Brouwer N., van Amerongen M., Liem R. S., Boddeke H. W., and, Biber K., (2005) Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J. Neurosci. 25, 7548-7557. (Pubitemid 41170612)
44. de Jong E. K., Vinet J., Stanulovic V. S., Meijer M., Wesseling E., Sjollema K., Boddeke H. W., and, Biber K., (2008) Expression, transport, and axonal sorting of neuronal CCL21 in large dense-core vesicles. FASEB J. 22, 4136-4145.
45. Jung H., Toth P. T., White F. A., and, Miller R. J., (2008) Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J. Neurochem. 104, 254-263. (Pubitemid 350265055)
46. Kaul M., and, Lipton S. A., (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 8212-8216. (Pubitemid 29328434)
47. Khasabova I. A., Stucky C. L., Harding-Rose C., Eikmeier L., Beitz A. J., Coicou L. G., Hanson A. E., Simone D. A., and, Seybold V. S., (2007) Chemical interactions between fibrosarcoma cancer cells and sensory neurons contribute to cancer pain. J. Neurosci. 27, 10289-10298. (Pubitemid 47450473)
48. Kordon C., and, Bihoreau C., (1989) Integrated communication between the nervous, endocrine and immune systems. Horm. Res. 31, 100-104. (Pubitemid 19125714)
49. Kurkowska-Jastrzebska I., Wronska A., Kohutnicka M., Czlonkowski A., and, Czlonkowska A., (1999) The inflammatory reaction following 1-methyl-4-phenyl-1, 2,3, 6-tetrahydropyridine intoxication in mouse. Exp. Neurol. 156, 50-61. (Pubitemid 29152982)
50. Lax P., Limatola C., Fucile S., Trettel F., Di Bartolomeo S., Renzi M., Ragozzino D., and, Eusebi F., (2002) Chemokine receptor CXCR2 regulates the functional properties of AMPA-type glutamate receptor GluR1 in HEK cells. J. Neuroimmunol. 129, 66-73. (Pubitemid 34874911)
51. Li M., and, Ransohoff R. M., (2008) Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 84, 116-131.
52. Lieberam I., Agalliu D., Nagasawa T., Ericson J., and, Jessell T. M., (2005) A Cxcl12-CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons. Neuron 47, 667-679. (Pubitemid 41208006)
53. Lindia J. A., McGowan E., Jochnowitz N., and, Abbadie C., (2005) Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J. Pain 6, 434-438. (Pubitemid 40922694)
54. Liu X. S., Zhang Z. G., Zhang R. L., Gregg S. R., Wang L., Yier T., and, Chopp M., (2007) Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J. Neurosci. Res. 85, 2120-2125. (Pubitemid 47172143)
55. Lucas S. M., Rothwell N. J., and, Gibson R. M., (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232-S240. (Pubitemid 43077281)
56. MacLean D., and, Reichlin S., (1981). Neuroendocrinology and the Immune Process, pp. 475-520. Academic Press, Orlando.
57. Martin-Garcia J., Kolson D. L., and, Gonzalez-Scarano F., (2002) Chemokine receptors in the brain: their role in HIV infection and pathogenesis. Aids 16, 1709-1730.
58. Mattson M. P., (2008) Hormesis defined. Ageing Res. Rev. 7, 1-7.
59. McGeer P. L., Schwab C., Parent A., and, Doudet D., (2003) Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine administration. Ann. Neurol. 54, 599-604. (Pubitemid 37346066)
60. McMahon S. B., Cafferty W. B., and, Marchand F., (2005) Immune and glial cell factors as pain mediators and modulators. Exp. Neurol. 192, 444-462. (Pubitemid 40341688)
61. McQuibban G. A., Butler G. S., Gong J. H., Bendall L., Power C., Clark-Lewis I., and, Overall C. M., (2001) Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276, 43503-43508.
62. Melik-Parsadaniantz S., and, Rostene W., (2008) Chemokines and neuromodulation. J. Neuroimmunol. 198, 62-68.
63. Menetski J., Mistry S., Lu M., Mudgett J. S., Ransohoff R. M., Demartino J. A., MacIntyre D. E., and, Abbadie C., (2007) Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience 149, 706-714. (Pubitemid 47633032)
64. Meucci O., (2010) Chemokine Receptors Function and NeuroAIDS. Springer, New York.
65. Meucci O., Fatatis A., Simen A. A., Bushell T. J., Gray P. W., and, Miller R. J., (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14500-14505. (Pubitemid 28549396)
66. Miller R. J., and, Meucci O., (1999) AIDS and the brain: is there a chemokine connection? Trends Neurosci. 22, 471-479. (Pubitemid 29447732)
67. Miller R. J., Rostene W., Apartis E., Banisadr G., Biber K., Milligan E. D., White F. A., and, Zhang J., (2008a) Chemokine action in the nervous system. J. Neurosci. 28, 11792-11795.
68. Miller R. J., Banisadr G., and, Bhattacharyya B. J., (2008b) CXCR4 signaling in the regulation of stem cell migration and development. J. Neuroimmunol. 198, 31-38.
69. Milligan E. D., Zapata V., Chacur M., et al. (2004) Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. 20, 2294-2302. (Pubitemid 39472392)
70. Milligan E., Zapata V., Schoeniger D., Chacur M., Green P., Poole S., Martin D., Maier S. F., and, Watkins L. R., (2005) An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur. J. Neurosci. 22, 2775-2782. (Pubitemid 41811274)
71. Nair A., Frederick T. J., and, Miller S. D., (2008) Astrocytes in multiple sclerosis: a product of their environment. Cell. Mol. Life Sci. 65, 2702-2720.
72. Oberlin E., Amara A., Bachelerie F., et al. (1996) The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835. (Pubitemid 26299571)
73. Oh S. B., Tran P. B., Gillard S. E., Hurley R. W., Hammond D. L., and, Miller R. J., (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 21, 5027-5035. (Pubitemid 32622928)
74. Ohab J. J., and, Carmichael S. T., (2008) Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist 14, 369-380. (Pubitemid 352010071)
75. Ohab J. J., Fleming S., Blesch A., and, Carmichael S. T., (2006) A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26, 13007-13016. (Pubitemid 44954619)
76. Peters C. M., and, Eisenach J. C., (2010) Contribution of the chemokine (C-C motif) ligand 2 (CCL2) to mechanical hypersensitivity after surgical incision in rats. Anesthesiology 112, 1250-1258.
77. Piccinin S., Di Angelantonio S., Piccioni A., Volpini R., Cristalli G., Fredholm B. B., Limatola C., Eusebi F., and, Ragozzino D., (2010) CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. J. Neuroimmunol. 224, 85-92.
78. Prinz M., and, Priller J., (2010) Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J. Neuroimmunol. 224, 80-84.
79. Przedborski S., (2010) Inflammation and Parkinson's disease pathogenesis. Mov. Disord. 25, S55-S57.
80. Pujol F., Kitabgi P., and, Boudin H., (2005) The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 118, 1071-1080. (Pubitemid 40484895)
81. Qin X., Wan Y., and, Wang X., (2005) CCL2 and CXCL1 trigger calcitonin gene-related peptide release by exciting primary nociceptive neurons. J. Neurosci. Res. 82, 51-62. (Pubitemid 41604797)
82. Ragozzino D., Renzi M., Giovannelli A., and, Eusebi F., (2002) Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J. Neuroimmunol. 127, 30-36. (Pubitemid 34606014)
83. Ransohoff R. M., (2009) Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31, 711-721.
84. Ransohoff R. M., Hamilton T. A., Tani M., Stoler M. H., Shick H. E., Major J. A., Estes M. L., Thomas D. M., and, Tuohy V. K., (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600. (Pubitemid 23120908)
85. Ransohoff R. M., Suzuki K., Proudfoot A. E., Hickey W. F., and, Harrison J. K., (2002) Universes in Delicate Balance. Elsevier, Amsterdam.
86. Rappert A., Biber K., Nolte C., Lipp M., Schubel A., Lu B., Gerard N. P., Gerard C., Boddeke H. W., and, Kettenmann H., (2002) Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl- current and chemotaxis in murine microglia. J. Immunol. 168, 3221-3226. (Pubitemid 34250381)
87. Rappert A., Bechmann I., Pivneva T., et al. (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 24, 8500-8509. (Pubitemid 39313773)
88. Reaux Le Goazigo A., Pohl M., and, Melik-Parsadaniantz S., (2010) New insights in the subcellular biology of SDF-1/CXCR4: synthesis, trafficking and neurosecretion: implications in nociception. In 13th world congress on pain. International Association for the Study of Pain, Montreal, Canada, PT 167.
89. Rostasy K., Egles C., Chauhan A., Kneissl M., Bahrani P., Yiannoutsos C., Hunter D. D., Nath A., Hedreen J. C., and, Navia B. A., (2003) SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J. Neuropathol. Exp. Neurol. 62, 617-626. (Pubitemid 36682634)
90. Rostene W. H., (1984) Neurobiological and neuroendocrine functions of the vasoactive intestinal peptide (VIP). Prog. Neurobiol. 22, 103-129. (Pubitemid 14057974)
91. Rostene W., Kitabgi P., and, Parsadaniantz S. M., (2007) Chemokines: a new class of neuromodulator? Nat. Rev. Neurosci. 8, 895-903.
92. Rostene W., Guyon A., Kular L., et al. (2011) Chemokines and chemokine receptors: new actors in neuroendocrine regulations. Front. Neuroendocrinol. 32, 10-24.
93. Saederup N., Cardona A. E., Croft K., Mizutani M., Cotleur A. C., Tsou C. L., Ransohoff R. M., and, Charo I. F., (2010) Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE 5, e13693-e13705.
94. Sanchez A., Tripathy D., and, Grammas P., (2009) RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons. Neuropeptides 43, 315-320.
95. Sanchez-Alcaniz J. A., Haege S., Mueller W., Pla R., Mackay F., Schulz S., Lopez-Bendito G., Stumm R., and, Marin O., (2011) Cxcr7 controls neuronal migration by regulating chemokine responsiveness. Neuron 69, 77-90.
96. Sautter N. B., Shick E. H., Ransohoff R. M., Charo I. F., and, Hirose K., (2006) CC chemokine receptor 2 is protective against noise-induced hair cell death: studies in CX3CR1(+/GFP) mice. J. Assoc. Res. Otolaryngol. 7, 361-372. (Pubitemid 44749160)
97. Schmid C. D., Melchior B., Masek K., Puntambekar S. S., Danielson P. E., Lo D. D., Sutcliffe J. G., and, Carson M. J., (2009) Differential gene expression in LPS/IFNgamma activated microglia and macrophages: in vitro versus in vivo. J. Neurochem. 109 (Suppl 1), 117-125.
98. Schonemeier B., Kolodziej A., Schulz S., Jacobs S., Hoellt V., and, Stumm R., (2008) Regional and cellular localization of the CXCL12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J. Comp. Neurol. 510, 207-220.
99. Sciaccaluga M., Fioretti B., Catacuzzeno L., et al. (2010) CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity. Am. J. Physiol. Cell Physiol. 299, C175-C184.
100. Semple B. D., Kossmann T., and, Morganti-Kossmann M. C., (2010) Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J. Cereb. Blood Flow Metab. 30, 459-473.
101. Serrano A., Pare M., McIntosh F., et al. (2010) Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol. Pain 6, 90-104.
102. Skrzydelski D., Guyon A., Dauge V., Rovere C., Apartis E., Kitabgi P., Nahon J. L., Rostene W., and, Parsadaniantz S. M., (2007) The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 102, 1175-1183. (Pubitemid 47174242)
103. Spangelo B. L., and, Gorospe W. C., (1995) Role of the cytokines in the neuroendocrine-immune system axis. Front. Neuroendocrinol. 16, 1-22.
104. Staniland A. A., Clark A. K., Wodarski R., Sasso O., Maione F., D'Acquisto F., and, Malcangio M., (2010) Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. J. Neurochem. 114, 1143-1157.
105. Struthers M., and, Pasternak A., (2010) CCR2 antagonists. Curr. Top. Med. Chem. 10, 1278-1298.
106. Stumm R. K., Rummel J., Junker V., Culmsee C., Pfeiffer M., Krieglstein J., Hollt V., and, Schulz S., (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J. Neurosci. 22, 5865-5878. (Pubitemid 35387631)
107. Stumm R. K., Zhou C., Ara T., Lazarini F., Dubois-Dalcq M., Nagasawa T., Hollt V., and, Schulz S., (2003) CXCR4 regulates interneuron migration in the developing neocortex. J. Neurosci. 23, 5123-5130. (Pubitemid 36793240)
108. Sun J. H., Yang B., Donnelly D. F., Ma C., and, LaMotte R. H., (2006) MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J. Neurophysiol. 96, 2189-2199. (Pubitemid 44785875)
109. Tanaka T., Minami M., Nakagawa T., and, Satoh M., (2004) Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci. Res. 48, 463-469. (Pubitemid 38369344)
110. Thacker M. A., Clark A. K., Bishop T., Grist J., Yip P. K., Moon L. D., Thompson S. W., Marchand F., and, McMahon S. B., (2009) CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur. J. Pain 13, 263-272.
111. Tran P. B., and, Miller R. J., (2003) Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4, 444-455. (Pubitemid 37280166)
112. Van Steenwinckel J., Reaux Le Goazigo A., Pommier B., Mauborgne A., Dansereau M. A., Kitabgi P., Sarret P., Pohl M., and, Melik-Parsadaniantz S., (2011) CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J. Neurosci. 31, 5865-5875.
113. Verge G. M., Milligan E. D., Maier S. F., Watkins L. R., Naeve G. S., and, Foster A. C., (2004) Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20, 1150-1160. (Pubitemid 39233569)
114. Wallace V. C., Blackbeard J., Segerdahl A. R., Hasnie F., Pheby T., McMahon S. B., and, Rice A. S., (2007) Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 130, 2688-2702. (Pubitemid 47511710)
115. Walz D. A., Wu V. Y., de Lamo R., Dene H., and, McCoy L. E., (1977) Primary structure of human platelet factor 4. Thromb. Res. 11, 893-898. (Pubitemid 8251864)
116. White F. A., Bhangoo S. K., and, Miller R. J., (2005a) Chemokines: integrators of pain and inflammation. Nat. Rev. Drug Discov. 4, 834-844. (Pubitemid 41553964)
117. White F. A., Sun J., Waters S. M., Ma C., Ren D., Ripsch M., Steflik J., Cortright D. N., Lamotte R. H., and, Miller R. J., (2005b) Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc. Natl Acad. Sci. USA 102, 14092-14097. (Pubitemid 41377708)
118. White F. A., Jung H., and, Miller R. J., (2007) Chemokines and the pathophysiology of neuropathic pain. Proc. Natl Acad. Sci. USA 104, 20151-20158.
119. Whitton P. S., (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963-976. (Pubitemid 46628616)
120. Wilson N. M., Jung H., Ripsch M. S., Miller R. J., and, White F. A., (2008) Opioid-induced tactile hypernociception is attenuated by the CXCR4 antagonist, AMD3100, In Society for Neuroscience annual meeting, Washington, DC. Abstract #270.14.
121. Wilson E. H., Weninger W., and, Hunter C. A., (2010) Trafficking of immune cells in the central nervous system. J. Clin. Invest. 120, 1368-1379.
122. Wu V. Y., Walz D. A., and, McCoy L. E., (1977) Purification and characterization of human and bovine platelet factor 4. Prep. Biochem. 7, 479-493. (Pubitemid 8289806)
123. Yamamoto T., Yamashita A., Yamada K., and, Hata R., (2011) Immunohistochemical localization of chemokine CXCL14 in rat hypothalamic neurons. Neurosci. Lett. 487, 335-340.
124. Yan Y. P., Sailor K. A., Lang B. T., Park S. W., Vemuganti R., and, Dempsey R. J., (2007) Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 27, 1213-1224. (Pubitemid 46808712)
125. Yoshimura T., Matsushima K., Tanaka S., Robinson E. A., Appella E., Oppenheim J. J., and, Leonard E. J., (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc. Natl Acad. Sci. USA 84, 9233-9237.
126. Zhang J., and, De Koninck Y., (2006) Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J. Neurochem. 97, 772-783.
127. Zhang J., Shi X. Q., Echeverry S., Mogil J. S., De Koninck Y., and, Rivest S., (2007) Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J. Neurosci. 27, 12396-12406. (Pubitemid 350085465)
128. Zhao P., Waxman S. G., and, Hains B. C., (2007) Modulation of thalamic nociceptive processing after spinal cord injury through remote activation of thalamic microglia by cysteine cysteine chemokine ligand 21. J. Neurosci. 27, 8893-8902. (Pubitemid 47292772)
129. Zheng J., Thylin M. R., Ghorpade A., et al. (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J. Neuroimmunol. 98, 185-200. (Pubitemid 29317545)
130. Zou Y. R., Kottmann A. H., Kuroda M., Taniuchi I., and, Littman D. R., (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595-599. (Pubitemid 28319251)